Recent Updates
Recently added Catalysts
CLDX Positive Sentiment Score: 70/100

Celldex Therapeutics to Present at Cantor Global Healthcare Conference

Monday, September 25, 2023 1 min read
Key Takeaway: Celldex Therapeutics, Inc. has announced its participation in a fireside chat at the Cantor Global Healthcare Conference scheduled for September 26th. The event will feature management discussing the company's clinical-stage biotechnology advancements. A webcast will be available for live viewing and for 90 days afterward on their website, ensuring broad accessibility for interested stakeholders. Celldex focuses on developing monoclonal and bispecific antibodies aimed at treating serious diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Celldex is actively engaged in sharing its developments at a major healthcare conference.
  • The company is focused on addressing significant medical needs with its innovative therapies.
  • Investors have access to a webcast and a replay of the presentation, promoting transparency.

Full Press Release Details

HAMPTON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the Cantor Global Healthcare Conference on Tuesday, September 26th at 1:00 pm ET. A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.
Senior Vice President, Corporate Affairs & Administration
scavanaugh@celldex.com
ptill@meruadvisors.com

Frequently Asked Questions

When will Celldex participate in the Cantor Global Healthcare Conference?

Celldex will participate on September 26th at 1:00 pm ET.

How can I access the Celldex conference presentation?

The presentation will be available on their website's Events & Presentations page.

What type of company is Celldex Therapeutics?

Celldex is a clinical stage biotech company focused on monoclonal and bispecific antibodies.

What diseases does Celldex aim to address?

Celldex targets diseases with inadequate treatments, including cancer and inflammatory conditions.

Is there a replay of the Celldex event available?

Yes, a replay will be available for 90 days after the event.

Tags: CLDX Viatris Investor Conferences Healthcare Celldex Therapeutics Cantor Global Healthcare Conference biotechnology clinical stage monoclonal antibodies
Last updated: Sep 25, 2023